1. Home
  2. ATRA vs CLPR Comparison

ATRA vs CLPR Comparison

Compare ATRA & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • CLPR
  • Stock Information
  • Founded
  • ATRA 2012
  • CLPR 2015
  • Country
  • ATRA United States
  • CLPR United States
  • Employees
  • ATRA N/A
  • CLPR N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • CLPR Real Estate Investment Trusts
  • Sector
  • ATRA Health Care
  • CLPR Real Estate
  • Exchange
  • ATRA Nasdaq
  • CLPR Nasdaq
  • Market Cap
  • ATRA 51.1M
  • CLPR 57.8M
  • IPO Year
  • ATRA 2014
  • CLPR 2017
  • Fundamental
  • Price
  • ATRA $11.58
  • CLPR $3.71
  • Analyst Decision
  • ATRA Strong Buy
  • CLPR
  • Analyst Count
  • ATRA 4
  • CLPR 0
  • Target Price
  • ATRA $20.00
  • CLPR N/A
  • AVG Volume (30 Days)
  • ATRA 57.7K
  • CLPR 100.2K
  • Earning Date
  • ATRA 08-11-2025
  • CLPR 08-04-2025
  • Dividend Yield
  • ATRA N/A
  • CLPR 10.24%
  • EPS Growth
  • ATRA N/A
  • CLPR N/A
  • EPS
  • ATRA N/A
  • CLPR N/A
  • Revenue
  • ATRA $199,732,000.00
  • CLPR $152,413,000.00
  • Revenue This Year
  • ATRA N/A
  • CLPR N/A
  • Revenue Next Year
  • ATRA N/A
  • CLPR N/A
  • P/E Ratio
  • ATRA N/A
  • CLPR N/A
  • Revenue Growth
  • ATRA 475.53
  • CLPR 8.63
  • 52 Week Low
  • ATRA $5.01
  • CLPR $3.44
  • 52 Week High
  • ATRA $18.71
  • CLPR $7.12
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 66.87
  • CLPR 44.89
  • Support Level
  • ATRA $8.53
  • CLPR $3.72
  • Resistance Level
  • ATRA $13.46
  • CLPR $4.39
  • Average True Range (ATR)
  • ATRA 0.96
  • CLPR 0.19
  • MACD
  • ATRA 0.28
  • CLPR 0.01
  • Stochastic Oscillator
  • ATRA 62.65
  • CLPR 20.07

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About CLPR Clipper Realty Inc.

Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.

Share on Social Networks: